Ceppo probiotico
Saccharomyces boulardii CNCM I-3799
Aree terapeutiche
Funzionalità
Fonti
Samir Jawhara, Daniel Poulain, Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis, Medical Mycology, Volume 45, Issue 8, December 2007, Pages 691–700
Krasowska A, Murzyn A, Dyjankiewicz A, Łukaszewicz M, Dziadkowiec D. The antagonistic effect of Saccharomyces boulardii on Candida albicans filamentation, adhesion and biofilm formation. FEMS Yeast Res. 2009 Dec;9(8):1312-21.
Murzyn A, Krasowska A, Stefanowicz P, Dziadkowiec D, Łukaszewicz M (2010) Capric Acid Secreted by S. boulardii Inhibits C. albicans Filamentous Growth, Adhesion and Biofilm Formation. PLoS ONE 5(8): e12050.
Krasowska A, Murzyn A, Dyjankiewicz A, Łukaszewicz M, Dziadkowiec D. The antagonistic effect of Saccharomyces boulardii on Candida albicans filamentation, adhesion and biofilm formation. FEMS Yeast Res. 2009 Dec;9(8):1312-21.
Murzyn A, Krasowska A, Stefanowicz P, Dziadkowiec D, Łukaszewicz M (2010) Capric Acid Secreted by S. boulardii Inhibits C. albicans Filamentous Growth, Adhesion and Biofilm Formation. PLoS ONE 5(8): e12050.
Scopri i prodotti che lo contengono
Potrebbe interessarti anche:
News
Approfondimenti
Approfondimenti
Approfondimenti
Approfondimenti
Approfondimenti
Approfondimenti
Patologie
